Patent ID: 11883460
Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 0:
1. A process for manufacturing a medicament for treating a subject infected, suspected to be infected, or at risk of infection, with a multidrug resistant bacterium utilizing a dry powder inhaler (DPI) composition of antimicrobial agents comprising: a polymyxin antibiotic; and at least two further antibiotics selected from the group consisting of an aminoglycoside, an ansamycin, a carbacephem, a carbapenem, a cephalosporin, a glycopeptide, a lincosamide, a lipopeptide, a macrolide, a monobactam, a nitrofuran, a oxazolidonone, a penicillin, a polypeptide, a quinolone, a sulfonamide, a tetracycline, a chloramphenicol, a phosphonic acid antibiotic and a mycobacteria antibiotic, wherein the antimicrobial agents are spray dried with a 5.5 μm spray mesh size, and have a particle size of between about 1 and 5 μm.